PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Ganju, Vinod [1 ]
Pereira, Jose [2 ]
Kim, Joo-Hang [3 ]
Magallanes, Manuel [4 ]
Lee, Dae-Ho [5 ]
Wang, Jie [6 ]
Martinez, Luis [7 ]
Barraclough, Helen
Van Kooten, Maximiliano
Orlando, Mauro
机构：
[1] Frankston Private Hosp, Peninsula Oncol Ctr, Frankston, Vic, Australia
[2] Inst Arnaldo Vieira De Carvalho, Oncopneumol Dept, Sao Paulo, Brazil
[3] Yonsei Canc Ctr, Seoul, South Korea
[4] Mil Hosp Mexico, Dept Med Oncol, Mexico City, DF, Mexico
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Ulsan, South Korea
[6] Beijing Canc Hosp & Inst, Dept Thorac Oncol, Beijing, Peoples R China
[7] Natl Inst Resp Dis, Dept Oncol, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Pemetrexed; Docetaxel; Non-squamous nsmall cell lung cancer; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [41] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Lim, Kyu-Hyoung
    Lee, Hui-Young
    Song, Seo-Young
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4644 - 4648
  • [42] A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer
    Zarogoulidis, K
    Kontakiotis, T
    Hatziapostolou, P
    Fachantidou, E
    Delis, D
    Goutsikas, J
    Constantinidis, TC
    Athanasiadis, A
    Patakas, D
    LUNG CANCER, 2001, 32 (03) : 281 - 287
  • [43] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [44] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
    Niho, Seiji
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Horai, Takeshi
    Ichinose, Yukito
    Hida, Toyoaki
    Yamamoto, Nobuyuki
    Kawahara, Masaaki
    Shinkai, Tetsu
    Nakagawa, Kazuhiko
    Matsui, Kaoru
    Negoro, Shunichi
    Yokoyama, Akira
    Kudoh, Shinzoh
    Kiura, Katsuyuki
    Mori, Kiyoshi
    Okamoto, Hiroaki
    Sakai, Hiroshi
    Takeda, Koji
    Yokota, Soichiro
    Saijo, Nagahiro
    Fukuoka, Masahiro
    LUNG CANCER, 2012, 76 (03) : 362 - 367
  • [45] Retrospective analysis of administration of a combination of docetaxel and carboplatin for advanced non-small cell lung cancer
    Bando, H
    Miyata, J
    Sano, T
    Sumitomo, M
    ANTICANCER RESEARCH, 2001, 21 (3C) : 2107 - 2113
  • [46] A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
    Fung, A. S.
    Graham, D. M.
    Chen, E. X.
    Stockley, T. L.
    Zhang, T.
    Le, L. W.
    Albaba, H.
    Pisters, K. M.
    Bradbury, P. A.
    Trinkaus, M.
    Chan, M.
    Arif, S.
    Zurawska, U.
    Rothenstein, J.
    Zawisza, D.
    Effendi, S.
    Gill, S.
    Sawczak, M.
    Law, J. H.
    Leighl, N. B.
    LUNG CANCER, 2021, 157 : 21 - 29
  • [47] Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer
    Laack, E
    Dierlamm, T
    Knuffmann, C
    Popp, J
    Schmied, B
    Dürk, H
    Wacker-Backerhaus, G
    Zeller, W
    Verpoort, K
    Fiedler, W
    Hossfeld, DK
    LUNG CANCER, 2002, 36 (03) : 303 - 307
  • [48] Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer
    Kim, Hyeong Su
    Kim, Jung Han
    Kim, Byounghoon
    Choi, Hyun Chang
    Kwon, Jung Hye
    Choi, Dae Ro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1591 - 1597
  • [49] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
  • [50] Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study
    Masato Karayama
    Naoki Inui
    Shigeki Kuroishi
    Koshi Yokomura
    Mikio Toyoshima
    Toshihiro Shirai
    Masafumi Masuda
    Takashi Yamada
    Kazumasa Yasuda
    Takafumi Suda
    Kingo Chida
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 445 - 452
12345